british american tobacco p.l.c. sustainability report 2011 - Harm reduction goals and commitments

Skip Data Fast Track Navigation

Data fast track

Sustainability Report 2011

Our harm reduction commitment

We will strive to bring commercially viable, consumer acceptable reduced-risk products to market.

2012 goals

  • Take our laboratory models of diseases through an external validation phase involving collaborative research with scientific partners by end 2013;
  • Register and undertake a longer clinical study of biomarkers of exposure to tobacco smoke toxicants and biomarkers of biological effect under ethical approval and to high clinical standards by end 2012;
  • Submit for publication more of our research on the tobacco genome and undertake further field trials on tobacco plants with lower toxicant levels by end 2012; and 
  • Present our scientific findings at international conferences and continue to improve the standard of our publications in peer-reviewed journals.


Back to top